This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Acuvi Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Acuvi has a total shareholder equity of SEK281.8M and total debt of SEK56.5M, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are SEK404.7M and SEK123.0M respectively. Acuvi's EBIT is SEK29.3M making its interest coverage ratio 58.4. It has cash and short-term investments of SEK15.3M.

Belangrijke informatie

20.0%

Verhouding schuld/eigen vermogen

SEK 56.49m

Schuld

Rente dekkingsratio58.4x
ContantSEK 15.30m
AandelenSEK 281.77m
Totaal verplichtingenSEK 122.97m
Totaal activaSEK 404.75m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Geen updates

Analyse van de financiële positie

Kortlopende schulden: ACUVI BTA's short term assets (SEK100.9M) exceed its short term liabilities (SEK64.4M).

Langlopende schulden: ACUVI BTA's short term assets (SEK100.9M) exceed its long term liabilities (SEK58.6M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ACUVI BTA's net debt to equity ratio (14.6%) is considered satisfactory.

Schuld verminderen: ACUVI BTA's debt to equity ratio has increased from 6.1% to 20% over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Whilst unprofitable ACUVI BTA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Voorspelling contante baan: ACUVI BTA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 10.2% per year.


Ontdek gezonde bedrijven